1. Exploring the effect of hydroxyapatite nanoparticle shape on red blood cells and blood coagulation.
- Author
-
Sun, Weitang, Li, Jiali, Zhong, Jingbin, Feng, Jieling, Ye, Zijie, Lin, Yueling, Su, Wenqi, Zhu, Shibo, Li, Yinghua, and Jia, Wei
- Abstract
Aim: In this study, we evaluated the effects of two types of hydroxyapatite (HAP) nanoparticles, sharing the same surface chemistry but differing in shape, on the biological characteristics of plasma, platelets and red blood cells. Materials & methods: Initially, two different shapes (rod-shaped and sphere-shaped) of HAPs were characterized. These HAPs were then co-cultured with plasma and red blood cells to examine their impact on coagulation and hemolysis. The impact of HAPs on white blood cells count in mice were evaluated following gavage and tail vein injection. Results: Sphere-shaped HAP is more likely to adsorb onto platelet surfaces, while rod-shaped HAP is more likely to cause hemolysis. Although there are differences in the in vitro experimental results between sphere-shaped HAP and rod-shaped HAP, both types demonstrate good blood compatibility at a 20 mM concentration. Furthermore, in vivo experiments showed that sphere-shaped nano-HAP induced a more pronounced increase in white blood cell count, suggesting that it may exhibit greater toxicity. Conclusion: While differences exist in the blood compatibility test results between the two HAPs, these differences are minimal, with both results falling within a safe range. Overall, HAP demonstrates excellent blood compatibility. Article highlights Despite the increasingly widespread application of nanoparticles in the biomedical field, the impact of nanoparticle shape on the biological characteristics of blood cells and plasma components remains inadequately characterized. To address this knowledge gap, we conducted a systematic evaluation of the biological effects of two hydroxyapatite (HAP) nanoparticle suspensions with different shapes (rod-shaped and sphere-shaped) but identical surface chemical properties on various blood components, including coagulation factors, platelets and red blood cells. Our findings demonstrated that these two HAP nanoparticles did not cause adverse reactions, such as plasma coagulation, platelet activation or red blood cell hemolysis at a concentration of 20 mM, indicating their good blood compatibility at this concentration. In vivo experiments at a dose of 500 μM/kg showed that both gastric lavage and tail vein injection of HAP induced an increase in white blood cell count in the experimental animals, indicating potential early and late inflammatory responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF